Table 1.

Antipsychotics and antidepressants in children and adolescents with Prader-Willi-Syndrome

Age (yr)/Gender	Psychotropic substance (dose, mg/d)	Efficiency			Side effects	Reference
		Aggressive behavior	Obsessive-compulsive behavior	Weight
Antidepressants
9/female	Fluoxetine (60)+naltrexone (60)	Reduction	–	Reduction	None reported	7
11/female	Fluoxetine (30)	No reduction	No reduction	–	None reported	8
11/female	Sertraline (75)	No reduction	No reduction	–	None reported	8
13/female	Fluoxetine (10)	–	–	No change	Psychosis	9
14/male	Fluoxetine (60)	Increase	Reduction	Increase	None reported	10
17/female	Fluoxetine (40)	Reduction	–	Reduction	None reported	11
14/male	Fluvoxamine (50–200)	Increase	Reduction	Increase	None reported	10
Antipsychotics
11/female	Aripiprazole (5–10)	Reduction	Reduction	–	None reported	8
11/male	Risperidone (0.5–1.5)	Reduction	–	Reduction	None reported	12
15/male	Risperidone (1.5)	Reduction	Reduction	Increase	None reported	13

–, no information.